1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of NGS-based RNA-seq

1.2 Classification of NGS-based RNA-seq by Type

1.2.1 Overview: Global NGS-based RNA-seq Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global NGS-based RNA-seq Revenue Market Share by Type in 2021

1.2.3 High-Throughput Sequencing

1.2.4 Third-Generation Sequencing Technology

1.3 Global NGS-based RNA-seq Market by Application

1.3.1 Overview: Global NGS-based RNA-seq Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals and Clinics

1.3.3 Biopharma Companies

1.3.4 Government Agencies

1.3.5 Academic and Research Organizations

1.3.6 Other

1.4 Global NGS-based RNA-seq Market Size & Forecast

1.5 Global NGS-based RNA-seq Market Size and Forecast by Region

1.5.1 Global NGS-based RNA-seq Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global NGS-based RNA-seq Market Size by Region, (2017-2022)

1.5.3 North America NGS-based RNA-seq Market Size and Prospect (2017-2028)

1.5.4 Europe NGS-based RNA-seq Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific NGS-based RNA-seq Market Size and Prospect (2017-2028)

1.5.6 South America NGS-based RNA-seq Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa NGS-based RNA-seq Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 NGS-based RNA-seq Market Drivers

1.6.2 NGS-based RNA-seq Market Restraints

1.6.3 NGS-based RNA-seq Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Illumina

2.1.1 Illumina Details

2.1.2 Illumina Major Business

2.1.3 Illumina NGS-based RNA-seq Product and Solutions

2.1.4 Illumina NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Illumina Recent Developments and Future Plans

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific NGS-based RNA-seq Product and Solutions

2.2.4 Thermo Fisher Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.3 Pacific Biosciences Of California

2.3.1 Pacific Biosciences Of California Details

2.3.2 Pacific Biosciences Of California Major Business

2.3.3 Pacific Biosciences Of California NGS-based RNA-seq Product and Solutions

2.3.4 Pacific Biosciences Of California NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Pacific Biosciences Of California Recent Developments and Future Plans

2.4 Qaigen

2.4.1 Qaigen Details

2.4.2 Qaigen Major Business

2.4.3 Qaigen NGS-based RNA-seq Product and Solutions

2.4.4 Qaigen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Qaigen Recent Developments and Future Plans

2.5 F. Hoffmann-La Roche

2.5.1 F. Hoffmann-La Roche Details

2.5.2 F. Hoffmann-La Roche Major Business

2.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Product and Solutions

2.5.4 F. Hoffmann-La Roche NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.6 Agilent Technologies

2.6.1 Agilent Technologies Details

2.6.2 Agilent Technologies Major Business

2.6.3 Agilent Technologies NGS-based RNA-seq Product and Solutions

2.6.4 Agilent Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Agilent Technologies Recent Developments and Future Plans

2.7 Oxford Nanopore Technologies

2.7.1 Oxford Nanopore Technologies Details

2.7.2 Oxford Nanopore Technologies Major Business

2.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Product and Solutions

2.7.4 Oxford Nanopore Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Oxford Nanopore Technologies Recent Developments and Future Plans

2.8 Perkinelmer

2.8.1 Perkinelmer Details

2.8.2 Perkinelmer Major Business

2.8.3 Perkinelmer NGS-based RNA-seq Product and Solutions

2.8.4 Perkinelmer NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Perkinelmer Recent Developments and Future Plans

2.9 Eurofins Scientific

2.9.1 Eurofins Scientific Details

2.9.2 Eurofins Scientific Major Business

2.9.3 Eurofins Scientific NGS-based RNA-seq Product and Solutions

2.9.4 Eurofins Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Eurofins Scientific Recent Developments and Future Plans

2.10 Gatc Biotech

2.10.1 Gatc Biotech Details

2.10.2 Gatc Biotech Major Business

2.10.3 Gatc Biotech NGS-based RNA-seq Product and Solutions

2.10.4 Gatc Biotech NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Gatc Biotech Recent Developments and Future Plans

2.11 Macrogen

2.11.1 Macrogen Details

2.11.2 Macrogen Major Business

2.11.3 Macrogen NGS-based RNA-seq Product and Solutions

2.11.4 Macrogen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Macrogen Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global NGS-based RNA-seq Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 NGS-based RNA-seq Players Market Share in 2021

3.2.2 Top 10 NGS-based RNA-seq Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 NGS-based RNA-seq Players Head Office, Products and Services Provided

3.4 NGS-based RNA-seq Mergers & Acquisitions

3.5 NGS-based RNA-seq New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global NGS-based RNA-seq Revenue and Market Share by Type (2017-2022)

4.2 Global NGS-based RNA-seq Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global NGS-based RNA-seq Revenue Market Share by Application (2017-2022)

5.2 Global NGS-based RNA-seq Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America NGS-based RNA-seq Revenue by Type (2017-2028)

6.2 North America NGS-based RNA-seq Revenue by Application (2017-2028)

6.3 North America NGS-based RNA-seq Market Size by Country

6.3.1 North America NGS-based RNA-seq Revenue by Country (2017-2028)

6.3.2 United States NGS-based RNA-seq Market Size and Forecast (2017-2028)

6.3.3 Canada NGS-based RNA-seq Market Size and Forecast (2017-2028)

6.3.4 Mexico NGS-based RNA-seq Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe NGS-based RNA-seq Revenue by Type (2017-2028)

7.2 Europe NGS-based RNA-seq Revenue by Application (2017-2028)

7.3 Europe NGS-based RNA-seq Market Size by Country

7.3.1 Europe NGS-based RNA-seq Revenue by Country (2017-2028)

7.3.2 Germany NGS-based RNA-seq Market Size and Forecast (2017-2028)

7.3.3 France NGS-based RNA-seq Market Size and Forecast (2017-2028)

7.3.4 United Kingdom NGS-based RNA-seq Market Size and Forecast (2017-2028)

7.3.5 Russia NGS-based RNA-seq Market Size and Forecast (2017-2028)

7.3.6 Italy NGS-based RNA-seq Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific NGS-based RNA-seq Revenue by Type (2017-2028)

8.2 Asia-Pacific NGS-based RNA-seq Revenue by Application (2017-2028)

8.3 Asia-Pacific NGS-based RNA-seq Market Size by Region

8.3.1 Asia-Pacific NGS-based RNA-seq Revenue by Region (2017-2028)

8.3.2 China NGS-based RNA-seq Market Size and Forecast (2017-2028)

8.3.3 Japan NGS-based RNA-seq Market Size and Forecast (2017-2028)

8.3.4 South Korea NGS-based RNA-seq Market Size and Forecast (2017-2028)

8.3.5 India NGS-based RNA-seq Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia NGS-based RNA-seq Market Size and Forecast (2017-2028)

8.3.7 Australia NGS-based RNA-seq Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America NGS-based RNA-seq Revenue by Type (2017-2028)

9.2 South America NGS-based RNA-seq Revenue by Application (2017-2028)

9.3 South America NGS-based RNA-seq Market Size by Country

9.3.1 South America NGS-based RNA-seq Revenue by Country (2017-2028)

9.3.2 Brazil NGS-based RNA-seq Market Size and Forecast (2017-2028)

9.3.3 Argentina NGS-based RNA-seq Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa NGS-based RNA-seq Revenue by Type (2017-2028)

10.2 Middle East & Africa NGS-based RNA-seq Revenue by Application (2017-2028)

10.3 Middle East & Africa NGS-based RNA-seq Market Size by Country

10.3.1 Middle East & Africa NGS-based RNA-seq Revenue by Country (2017-2028)

10.3.2 Turkey NGS-based RNA-seq Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia NGS-based RNA-seq Market Size and Forecast (2017-2028)

10.3.4 UAE NGS-based RNA-seq Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global NGS-based RNA-seq Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global NGS-based RNA-seq Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market NGS-based RNA-seq Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global NGS-based RNA-seq Revenue (USD Million) by Region (2017-2022)

Table 5. Global NGS-based RNA-seq Revenue Market Share by Region (2023-2028)

Table 6. Illumina Corporate Information, Head Office, and Major Competitors

Table 7. Illumina Major Business

Table 8. Illumina NGS-based RNA-seq Product and Solutions

Table 9. Illumina NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fisher Scientific Major Business

Table 12. Thermo Fisher Scientific NGS-based RNA-seq Product and Solutions

Table 13. Thermo Fisher Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Pacific Biosciences Of California Corporate Information, Head Office, and Major Competitors

Table 15. Pacific Biosciences Of California Major Business

Table 16. Pacific Biosciences Of California NGS-based RNA-seq Product and Solutions

Table 17. Pacific Biosciences Of California NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Qaigen Corporate Information, Head Office, and Major Competitors

Table 19. Qaigen Major Business

Table 20. Qaigen NGS-based RNA-seq Product and Solutions

Table 21. Qaigen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 23. F. Hoffmann-La Roche Major Business

Table 24. F. Hoffmann-La Roche NGS-based RNA-seq Product and Solutions

Table 25. F. Hoffmann-La Roche NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 27. Agilent Technologies Major Business

Table 28. Agilent Technologies NGS-based RNA-seq Product and Solutions

Table 29. Agilent Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Oxford Nanopore Technologies Corporate Information, Head Office, and Major Competitors

Table 31. Oxford Nanopore Technologies Major Business

Table 32. Oxford Nanopore Technologies NGS-based RNA-seq Product and Solutions

Table 33. Oxford Nanopore Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Perkinelmer Corporate Information, Head Office, and Major Competitors

Table 35. Perkinelmer Major Business

Table 36. Perkinelmer NGS-based RNA-seq Product and Solutions

Table 37. Perkinelmer NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Eurofins Scientific Corporate Information, Head Office, and Major Competitors

Table 39. Eurofins Scientific Major Business

Table 40. Eurofins Scientific NGS-based RNA-seq Product and Solutions

Table 41. Eurofins Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Gatc Biotech Corporate Information, Head Office, and Major Competitors

Table 43. Gatc Biotech Major Business

Table 44. Gatc Biotech NGS-based RNA-seq Product and Solutions

Table 45. Gatc Biotech NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Macrogen Corporate Information, Head Office, and Major Competitors

Table 47. Macrogen Major Business

Table 48. Macrogen NGS-based RNA-seq Product and Solutions

Table 49. Macrogen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Global NGS-based RNA-seq Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 51. Global NGS-based RNA-seq Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 52. Breakdown of NGS-based RNA-seq by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. NGS-based RNA-seq Players Head Office, Products and Services Provided

Table 54. NGS-based RNA-seq Mergers & Acquisitions in the Past Five Years

Table 55. NGS-based RNA-seq New Entrants and Expansion Plans

Table 56. Global NGS-based RNA-seq Revenue (USD Million) by Type (2017-2022)

Table 57. Global NGS-based RNA-seq Revenue Share by Type (2017-2022)

Table 58. Global NGS-based RNA-seq Revenue Forecast by Type (2023-2028)

Table 59. Global NGS-based RNA-seq Revenue by Application (2017-2022)

Table 60. Global NGS-based RNA-seq Revenue Forecast by Application (2023-2028)

Table 61. North America NGS-based RNA-seq Revenue by Type (2017-2022) & (USD Million)

Table 62. North America NGS-based RNA-seq Revenue by Type (2023-2028) & (USD Million)

Table 63. North America NGS-based RNA-seq Revenue by Application (2017-2022) & (USD Million)

Table 64. North America NGS-based RNA-seq Revenue by Application (2023-2028) & (USD Million)

Table 65. North America NGS-based RNA-seq Revenue by Country (2017-2022) & (USD Million)

Table 66. North America NGS-based RNA-seq Revenue by Country (2023-2028) & (USD Million)

Table 67. Europe NGS-based RNA-seq Revenue by Type (2017-2022) & (USD Million)

Table 68. Europe NGS-based RNA-seq Revenue by Type (2023-2028) & (USD Million)

Table 69. Europe NGS-based RNA-seq Revenue by Application (2017-2022) & (USD Million)

Table 70. Europe NGS-based RNA-seq Revenue by Application (2023-2028) & (USD Million)

Table 71. Europe NGS-based RNA-seq Revenue by Country (2017-2022) & (USD Million)

Table 72. Europe NGS-based RNA-seq Revenue by Country (2023-2028) & (USD Million)

Table 73. Asia-Pacific NGS-based RNA-seq Revenue by Type (2017-2022) & (USD Million)

Table 74. Asia-Pacific NGS-based RNA-seq Revenue by Type (2023-2028) & (USD Million)

Table 75. Asia-Pacific NGS-based RNA-seq Revenue by Application (2017-2022) & (USD Million)

Table 76. Asia-Pacific NGS-based RNA-seq Revenue by Application (2023-2028) & (USD Million)

Table 77. Asia-Pacific NGS-based RNA-seq Revenue by Region (2017-2022) & (USD Million)

Table 78. Asia-Pacific NGS-based RNA-seq Revenue by Region (2023-2028) & (USD Million)

Table 79. South America NGS-based RNA-seq Revenue by Type (2017-2022) & (USD Million)

Table 80. South America NGS-based RNA-seq Revenue by Type (2023-2028) & (USD Million)

Table 81. South America NGS-based RNA-seq Revenue by Application (2017-2022) & (USD Million)

Table 82. South America NGS-based RNA-seq Revenue by Application (2023-2028) & (USD Million)

Table 83. South America NGS-based RNA-seq Revenue by Country (2017-2022) & (USD Million)

Table 84. South America NGS-based RNA-seq Revenue by Country (2023-2028) & (USD Million)

Table 85. Middle East & Africa NGS-based RNA-seq Revenue by Type (2017-2022) & (USD Million)

Table 86. Middle East & Africa NGS-based RNA-seq Revenue by Type (2023-2028) & (USD Million)

Table 87. Middle East & Africa NGS-based RNA-seq Revenue by Application (2017-2022) & (USD Million)

Table 88. Middle East & Africa NGS-based RNA-seq Revenue by Application (2023-2028) & (USD Million)

Table 89. Middle East & Africa NGS-based RNA-seq Revenue by Country (2017-2022) & (USD Million)

Table 90. Middle East & Africa NGS-based RNA-seq Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. NGS-based RNA-seq Picture

Figure 2. Global NGS-based RNA-seq Revenue Market Share by Type in 2021

Figure 3. High-Throughput Sequencing

Figure 4. Third-Generation Sequencing Technology

Figure 5. NGS-based RNA-seq Revenue Market Share by Application in 2021

Figure 6. Hospitals and Clinics Picture

Figure 7. Biopharma Companies Picture

Figure 8. Government Agencies Picture

Figure 9. Academic and Research Organizations Picture

Figure 10. Other Picture

Figure 11. Global NGS-based RNA-seq Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global NGS-based RNA-seq Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global NGS-based RNA-seq Revenue Market Share by Region (2017-2028)

Figure 14. Global NGS-based RNA-seq Revenue Market Share by Region in 2021

Figure 15. North America NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. NGS-based RNA-seq Market Drivers

Figure 21. NGS-based RNA-seq Market Restraints

Figure 22. NGS-based RNA-seq Market Trends

Figure 23. Illumina Recent Developments and Future Plans

Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 25. Pacific Biosciences Of California Recent Developments and Future Plans

Figure 26. Qaigen Recent Developments and Future Plans

Figure 27. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 28. Agilent Technologies Recent Developments and Future Plans

Figure 29. Oxford Nanopore Technologies Recent Developments and Future Plans

Figure 30. Perkinelmer Recent Developments and Future Plans

Figure 31. Eurofins Scientific Recent Developments and Future Plans

Figure 32. Gatc Biotech Recent Developments and Future Plans

Figure 33. Macrogen Recent Developments and Future Plans

Figure 34. Global NGS-based RNA-seq Revenue Share by Players in 2021

Figure 35. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players NGS-based RNA-seq Revenue Market Share in 2021

Figure 37. Global Top 10 Players NGS-based RNA-seq Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global NGS-based RNA-seq Revenue Share by Type in 2021

Figure 40. Global NGS-based RNA-seq Market Share Forecast by Type (2023-2028)

Figure 41. Global NGS-based RNA-seq Revenue Share by Application in 2021

Figure 42. Global NGS-based RNA-seq Market Share Forecast by Application (2023-2028)

Figure 43. North America NGS-based RNA-seq Sales Market Share by Type (2017-2028)

Figure 44. North America NGS-based RNA-seq Sales Market Share by Application (2017-2028)

Figure 45. North America NGS-based RNA-seq Revenue Market Share by Country (2017-2028)

Figure 46. United States NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe NGS-based RNA-seq Sales Market Share by Type (2017-2028)

Figure 50. Europe NGS-based RNA-seq Sales Market Share by Application (2017-2028)

Figure 51. Europe NGS-based RNA-seq Revenue Market Share by Country (2017-2028)

Figure 52. Germany NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific NGS-based RNA-seq Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific NGS-based RNA-seq Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific NGS-based RNA-seq Revenue Market Share by Region (2017-2028)

Figure 60. China NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America NGS-based RNA-seq Sales Market Share by Type (2017-2028)

Figure 67. South America NGS-based RNA-seq Sales Market Share by Application (2017-2028)

Figure 68. South America NGS-based RNA-seq Revenue Market Share by Country (2017-2028)

Figure 69. Brazil NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa NGS-based RNA-seq Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa NGS-based RNA-seq Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Country (2017-2028)

Figure 74. Turkey NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE NGS-based RNA-seq Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source